{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "East Windsor",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78791",
      "recalling_firm": "SHISEIDO AMERICA INC.",
      "address_1": "366 Princeton Hightstown Rd",
      "address_2": "N/A",
      "postal_code": "08520-1411",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed nationwide.",
      "recall_number": "D-0218-2018",
      "product_description": "Shiseido Future Solutions LX Triple Points Bonus contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022, NDC 58411-256-60",
      "product_quantity": "N/A",
      "reason_for_recall": "GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.",
      "recall_initiation_date": "20171214",
      "center_classification_date": "20180112",
      "termination_date": "20210624",
      "report_date": "20180124",
      "code_info": "SKU#: 95284"
    }
  ]
}